| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anesthesia and
Biostatistics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Address correspondence to: Dr Anil Agarwal, Type IV/48, SGPGIMS, Lucknow 226 014, India. Fax: +91 522 2668017, 2668047, 2668078; E-mail: aagarwal{at}sgpgi.ac.in
Purpose: Fentanyl, a synthetic opioid, is a popular choice amongst anesthesiologists in the operating room. Preinduction iv fentanyl bolus is associated with coughing in 2845% of patients. Coughing due to fentanyl is not always benign and at times may be explosive requiring immediate intervention. We have studied the role of aerosol inhalation of salbutamol, beclomethasone and sodium chromoglycate in preventing fentanyl induced coughing and have compared their efficacy.
Methods: Two hundred patients aged 1860 yr, undergoing elective laparoscopic cholecystectomy were randomized into four groups of 50 each. Group I served as control, while Groups II, III and IV received an aerosol inhalation of salbutamol, beclomethasone or sodium chromoglycate 15 min prior to entering the operating room. Following iv fentanyl (2 µgkg-1) the incidence of cough was recorded and graded as mild (12), moderate (35) and severe (> 5) depending on the number of coughs observed. Results were analyzed using z and Fischers Exact test. A P value of
0.05 was considered significant.
Results: The incidence of cough was 28% in the control group, 6%, 0% and 4% in the salbutamol, beclomethasone and sodium chromoglycate groups respectively. Occurrence of cough was significantly low (P
0.05) in the treatment groups, however the difference amongst the groups was not significant (P
0.05).
Conclusion: The use of salbutamol, beclomethasone or sodium chromoglycate aerosol 15 min prior to iv fentanyl administration minimizes fentanyl-induced coughing.
This article has been cited by other articles:
![]() |
T. Oshima, Y. Kasuya, Y. Okumura, T. Murakami, and S. Dohi Identification of independent risk factors for fentanyl-induced cough: [L'identification de facteurs de risque independants pour la toux induite par le fentanyl]. Can J Anesth, August 1, 2006; 53(8): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Lin, C.-C. Yeh, M.-S. Lee, C.-T. Wu, S.-L. Lin, and C.-S. Wong Prolonged Injection Time and Light Smoking Decrease the Incidence of Fentanyl-Induced Cough Anesth. Analg., September 1, 2005; 101(3): 670 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Pandey, M. Raza, R. Ranjan, V. Singhal, M. Kumar, A. Lakra, D. V. Navkar, A. Agarwal, R. B. Singh, U. Singh, et al. Intravenous lidocaine 0.5 mg{middle dot}kg-1 effectively suppresses fentanyl-induced cough: [L'administration iv de 0,5 mg{middle dot}kg-1 de lidocaine supprime efficacement la toux induite par le fentanyl] Can J Anesth, February 1, 2005; 52(2): 172 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Pandey, M. Raza, R. Ranjan, A. Lakra, A. Agarwal, U. Singh, R. B. Singh, and P. K. Singh Intravenous Lidocaine Suppresses Fentanyl-Induced Coughing: A Double-Blind, Prospective, Randomized Placebo-Controlled Study Anesth. Analg., December 1, 2004; 99(6): 1696 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Lin, W.-Z. Sun, W.-H. Chan, C.-J. Lin, H.-M. Yeh, and M. S. Mok Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough: [L'administration iv de lidocaine et d'ephedrine, mais non de propofol, supprime la toux causee par le fentanyl] Can J Anesth, August 1, 2004; 51(7): 654 - 659. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |